Ali, Sapya S.

HRN: 10-74-98  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/13/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/13/2026
03/19/2026
IV
600 MG
Q8
CELLULITIS
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: